Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover
Steffi Oesterreich(University of Pittsburgh), David A. Flockhart(Indiana University – Purdue University Indianapolis), Catherine Van Poznak(University of Michigan), Jessica Dantzer(University School), Anne Nguyen(Indiana University School of Medicine), James M. Rae(University of Michigan), Anna Maria Storniolo(Indiana University Health), Vered Stearns(Johns Hopkins University), Kelley M. Kidwell(University of Michigan), N. Lynn Henry(University of Michigan), Daniel F. Hayes(University of Michigan–Ann Arbor), Santosh Philips(Indiana University School of Medicine), Zeruesenay Desta(Indiana University School of Medicine), Lang Li(Nanjing Agricultural University), Thomas N. Hangartner(Wright State University), Munro Peacock(Indiana University School of Medicine), Todd C. Skaar(Indiana University School of Medicine)
Cited by 35
Related Papers
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k